On 2016 Feb 10, Anders von Heijne commented:
A search of the EudraVigilance (European Union Drug Regulating Authorities Pharmacovigilance)database in February 2016 shows a further ten reported cases of PRES in fingolimod treated patients - seven in the USA and one each in Spain, Germany and Australia.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.